Shanghai MicroPort Endovascular MedTech Co., Ltd. Stock price

Equities

688016

CNE100003MJ5

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
181.6 CNY +4.04% Intraday chart for Shanghai MicroPort Endovascular MedTech Co., Ltd. +0.73% -6.69%
Sales 2024 * 1.53B 211M Sales 2025 * 2.01B 278M Capitalization 15.02B 2.08B
Net income 2024 * 623M 86.26M Net income 2025 * 801M 111M EV / Sales 2024 * 8.52 x
Net cash position 2024 * 2.02B 280M Net cash position 2025 * 2.24B 311M EV / Sales 2025 * 6.37 x
P/E ratio 2024 *
23.5 x
P/E ratio 2025 *
17.1 x
Employees 786
Yield 2024 *
1.55%
Yield 2025 *
1.93%
Free-Float 57.94%
More Fundamentals * Assessed data
Dynamic Chart
Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
MicroPort Scientific Unit to See Up to 38% Boost in 2023 Profit MT
Shanghai MicroPort Endovascular MedTech Co., Ltd. Provides Earnings Guidance for the Year Ended 31 December 2023 CI
EV MedTech Raises 1.8 Billion Yuan from Placement MT
MicroPort Endovascular MedTech Elects Chairman MT
Shanghai MicroPort Endovascular MedTech's Profit Up 29% in Q1-Q3 MT
Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Shanghai MicroPort Endovascular MedTech's H1 Attributable Profit Increases 30% MT
Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Shanghai Bourse Approves EV MedTech's Proposed Share Issuance MT
EV MedTech Expects Up to 30% Increase in First-Half Profit MT
Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Shanghai MicroPort Endovascular MedTech Co., Ltd. Provides Earnings Guidance for the Year Ended 31 December 2022 CI
Shanghai Hongmai Medical Technology Co., Ltd. announced that it expects to receive CNY 45 million in funding from Shanghai MicroPort Endovascular MedTech Co., Ltd., Shanghai Xiying Enterprise Consulting Partnership (Limited Partnership) CI
More news
1 day+4.04%
1 week+0.73%
Current month-3.64%
1 month+2.59%
3 months-5.22%
6 months-2.03%
Current year-6.69%
More quotes
1 week
172.02
Extreme 172.02
185.77
1 month
172.02
Extreme 172.02
193.19
Current year
147.01
Extreme 147.01
196.30
1 year
147.01
Extreme 147.01
210.30
3 years
133.04
Extreme 133.04
480.00
5 years
101.00
Extreme 101
480.00
10 years
101.00
Extreme 101
480.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 43 18-06-30
Director of Finance/CFO 44 21-10-27
Director/Board Member 44 14-06-30
Members of the board TitleAgeSince
Chairman 56 18-07-30
Director/Board Member 47 18-07-30
Director/Board Member 56 18-07-30
More insiders
Date Price Change Volume
24-03-28 181.6 +4.04% 1,193,284
24-03-27 174.6 -0.29% 520,869
24-03-26 175 +1.00% 507,467
24-03-25 173.3 -2.21% 490,074
24-03-22 177.2 -1.71% 505,754

End-of-day quote Shanghai S.E., March 27, 2024

More quotes
Shanghai MicroPort Endovascular MedTech Co., Ltd. is a China-based company principally engaged in the research and development, production and sales of aortic and peripheral vascular interventional medical devices. The Company's main products include the aortic stent graft system for aortic minimally invasive interventional procedures, the intraoperative stent system for open surgery, as well as the peripheral vascular stent system and peripheral balloon dilatation catheters for the treatment of peripheral vascular diseases. The Company mainly distributes its products to the domestic market.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
181.6 CNY
Average target price
238.4 CNY
Spread / Average Target
+31.26%
Consensus
  1. Stock
  2. Equities
  3. Stock Shanghai MicroPort Endovascular MedTech Co., Ltd. - Shanghai S.E.